Cleared Traditional

K010236 - IMMAGE IMMUNOCHEMISTRY SYSTEM HIGH SENSITIVITY C-REACTIVE PROTEIN (CRPH) REAGENT (FDA 510(k) Clearance)

Apr 2001
Decision
70d
Days
Class 2
Risk

K010236 is an FDA 510(k) clearance for the IMMAGE IMMUNOCHEMISTRY SYSTEM HIGH SENSITIVITY C-REACTIVE PROTEIN (CRPH) REAGENT. This device is classified as a C-reactive Protein, Antigen, Antiserum, And Control (Class II - Special Controls, product code DCK).

Submitted by Beckman Coulter, Inc. (Brea, US). The FDA issued a Cleared decision on April 5, 2001, 70 days after receiving the submission on January 25, 2001.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5270.

Submission Details

510(k) Number K010236 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 25, 2001
Decision Date April 05, 2001
Days to Decision 70 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code DCK — C-reactive Protein, Antigen, Antiserum, And Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5270